Tetramethylpyrazine alleviated cytokine synthesis and dopamine deficit and improved motor dysfunction in the mice model of Parkinson’s disease

Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap

Paolo Calabresi, Massimiliano Di Filippo, Veronica Ghiglieri et al. · The Lancet Neurology · 2010 · 379 citations · Full text

Medicine, Neurology, Pharmacotherapy +14

The Inflammatory Reaction Following 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Intoxication in Mouse

Iwona Kurkowska‐Jastrzębska, Aneta Wrońska, Małgorzata Kohutnicka et al. · Experimental Neurology · 1999 · 376 citations

Veterinary Medicine, Pharmacology, Toxicology +12

Cannabinoid Receptor Type 1 Protects Nigrostriatal Dopaminergic Neurons against MPTP Neurotoxicity by Inhibiting Microglial Activation

Young Cheul Chung, Eugene Bok, Sue H. Huh et al. · The Journal of Immunology · 2011 · 125 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Tetramethylpyrazine reduces cellular inflammatory response following permanent focal cerebral ischemia in rats

Tsung-Kuei Kao, Cheng-Yi Chang, Yen‐Chuan Ou et al. · Experimental Neurology · 2013 · 115 citations

Medicine, Neuroscience, Pharmacology +14

Tetramethylpyrazine protects spinal cord and reduces inflammation in a rat model of spinal cord ischemia-reperfusion injury

Lihong Fan, Kunzheng Wang, Zhibin Shi et al. · Journal of Vascular Surgery · 2011 · 91 citations · Full text

Medicine, Neuroscience, Pharmacology +12